Lea Darrell Shane 4
4 · Cellectar Biosciences, Inc. · Filed Dec 15, 2022
Insider Transaction Report
Form 4
Lea Darrell Shane
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2022-11-21+100,000→ 100,000 totalExercise: $1.90Exp: 2032-11-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date.